S2 Fig - by Aihong Zheng (20571034)

Fig 4 - by Aihong Zheng (20571034)

Antihypertensive treatment of 151 T2DM patients with hypertension at different subgroups. by Ningning Wang (560944)

The values of angiotensin II by Ningning Wang (560944)

A particular class of CSR 22Gs are up-regulated in synMuv B mutants. by Ashwin Seetharaman (615458)

Demographic structure and Employment categorization. by Nehal Mohamed Eisa (21148787)

Burn out assessment throughout demographic structure of the participant. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Emotional Exhaustion through demographic structure. by Nehal Mohamed Eisa (21148787)

Donut chart shows Demographic structure and Employment categorization. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Depersonalization through demographic structure. by Nehal Mohamed Eisa (21148787)

Stack column chart represent Personal Accomplishment through demographic structure. by Nehal Mohamed Eisa (21148787)

i & ii: PCA represent the (i) 2d and (ii) 3d to identify the underlying dimensions of the lifestyle questions. by Nehal Mohamed Eisa (21148787)

Heatmap represents the criterion of health lifestyle survey. (Color guide is provided above each figure). by Nehal Mohamed Eisa (21148787)

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)